- Aneta Sottil joined Andera Partners in January 2018. She serves as Partner in the Andera Life Sciences team, dedicated to investing in life sciences.
- Aneta has 14 years of experience in Life Sciences, gained in healthcare investment banking (BAML between 2006 and 2008; Rothschild between 2008 and 2013) and Venture Capital (Norgine Ventures between 2013 and 2018).
- She holds a Masters in Finance and Banking from Warsaw School of Economics, Singapore Management University and l’Université Pierre Mendès France.
- By origin Polish, Aneta also speaks English, French and Spanish. Aneta currently serves on the boards of Atlantic Therapeutics and Gamamabs.
Investments of Aneta
Dualyx
Biotech developing novel Treg therapies for autoimmune diseases
Ariceum
Novel medicines for systemic targeted radiotherapy to visualize and treat cancer
FIRE 1
Technology for heart failure patients
Atlantic Therapeutics
Dispositif d'électrostimulation pour l’incontinence urinaire d’effort
Axonics
Neurostimulateur implantable pour le traitement de l'incontinence urinaire
Corvidia Therapeutics
Molécule pour le traitement de l’inflammation chez les patients insuffisants rénaux
Enyo Pharma
Petites molécules pour le traitement de l’hépatite B chronique et de la NASH
GAMAMABS
Développement d'anticorps thérapeutiques optimisés pour le traitement du cancer
Medical Micro Instruments
Dispositif robotique pour des opérations de microchirurgie
Arvelle
Small molecule for the treatment of pharmacoresistant partial epilepsy
The team andera Life Sciences
Raphaël Wisniewski
Partner
Olivier Litzka
Partner
Sofia Ioannidou
Partner
Jan Van den Bossche
Partner
Gilles Nobécourt
Partner
Aneta Sottil
Partner
Mathieu Piéronne
Director
Yuexin Yu
Director
Natali Romero Barrios
Investment Manager
Yanis Feraoun
Analyst
Elyes Chouaieb
Investment Director
Loan Hoang-Sayag
Venture Partner
Florian Gerard-Mercier
Investment Manager
Emmanuelle Payet
Middle Office
Thierry Hercend
Venture Partner
Raymond W. Cohen
Venture Advisor
Vanessa Bonvalot
Executive Assistant